These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21864272)

  • 1. The pathology and immunology of atopic dermatitis.
    Rahman S; Collins M; Williams CM; Ma HL
    Inflamm Allergy Drug Targets; 2011 Dec; 10(6):486-96. PubMed ID: 21864272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of atopic dermatitis.
    Mu Z; Zhao Y; Liu X; Chang C; Zhang J
    Clin Rev Allergy Immunol; 2014 Oct; 47(2):193-218. PubMed ID: 24715253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppressive effect of puerarin on atopic dermatitis-like skin lesions through regulation of inflammatory mediators in vitro and in vivo.
    Lee JH; Jeon YD; Lee YM; Kim DK
    Biochem Biophys Res Commun; 2018 Apr; 498(4):707-714. PubMed ID: 29524423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.
    Komine M
    J Pharmacol Sci; 2009 Jul; 110(3):260-4. PubMed ID: 19609063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forsythia suspensa Suppresses House Dust Mite Extract-Induced Atopic Dermatitis in NC/Nga Mice.
    Sung YY; Yoon T; Jang S; Kim HK
    PLoS One; 2016; 11(12):e0167687. PubMed ID: 27936051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular aspects of atopic dermatitis.
    Ou LS; Huang JL
    Clin Rev Allergy Immunol; 2007 Dec; 33(3):191-8. PubMed ID: 18163225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes.
    Choi JK; Jang YH; Lee S; Lee SR; Choi YA; Jin M; Choi JH; Park JH; Park PH; Choi H; Kwon TK; Khang D; Kim SH
    Food Chem Toxicol; 2017 Dec; 110():142-150. PubMed ID: 29050978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocytes: innate immune cells in atopic dermatitis.
    Chieosilapatham P; Kiatsurayanon C; Umehara Y; Trujillo-Paez JV; Peng G; Yue H; Nguyen LTH; Niyonsaba F
    Clin Exp Immunol; 2021 Jun; 204(3):296-309. PubMed ID: 33460469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
    Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
    J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents.
    Luger T; Amagai M; Dreno B; Dagnelie MA; Liao W; Kabashima K; Schikowski T; Proksch E; Elias PM; Simon M; Simpson E; Grinich E; Schmuth M
    J Dermatol Sci; 2021 Jun; 102(3):142-157. PubMed ID: 34116898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.
    Vakharia PP; Silverberg JI
    BioDrugs; 2017 Oct; 31(5):409-422. PubMed ID: 28853008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis.
    Cheung PF; Wong CK; Ho AW; Hu S; Chen DP; Lam CW
    Int Immunol; 2010 Jun; 22(6):453-67. PubMed ID: 20410259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903.
    Moosbrugger-Martinz V; Schmuth M; Dubrac S
    Methods Mol Biol; 2017; 1559():91-106. PubMed ID: 28063040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IMMUNOLOGICAL AND NON-IMMUNOLOGICAL PATHOGENETIC MECHANISMS OF DEVELOPMENT OF COMPLICATED FORMS OF ATOPIC DERMATITIS (REVIEW)].
    Slavyanskaya T; Derkach V; Sepiashvili R
    Georgian Med News; 2015 Jun; (243):22-8. PubMed ID: 26087725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice.
    Kim JY; Jeong MS; Park MK; Lee MK; Seo SJ
    Exp Dermatol; 2014 Jan; 23(1):53-7. PubMed ID: 24299269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
    Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
    J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of toll-like receptor 3 inhibitors ameliorates chronic allergic skin inflammation in mice.
    Tamagawa-Mineoka R; Ueta M; Arakawa Y; Yasuike R; Nishigaki H; Okuno Y; Hijikuro I; Kinoshita S; Katoh N
    J Dermatol Sci; 2021 Feb; 101(2):141-144. PubMed ID: 33262024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.